scholarly journals Sclerema Neonatorum Treated Successfully with Parenteral Steroids: An Experience from a Resource Poor Country

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Sandeep Shrestha ◽  
Nagendra Chaudhary ◽  
Sujit Koirala ◽  
Ruchi Gupta

Sclerema neonatorum is a form of panniculitides characterized by diffuse hardening of subcutaneous tissue with minimal inflammation. It usually affects ill and preterm neonates. Prognosis is usually poor in many cases despite aggressive management. Various treatment modalities (antibiotics, intravenous immunoglobulin, steroids, and exchange transfusion) have been explained in literature. Steroids due to its easy availability and low cost can prove to be lifesaving in such cases, especially in resource poor countries. Here, we report a case of sclerema neonatorum in a one-week preterm baby treated successfully with parenteral steroids and antibiotics.

MedEdPublish ◽  
2018 ◽  
Vol 7 (3) ◽  
Author(s):  
Ninos Oussi ◽  
Mitra Sadeghi ◽  
Javeria S. Qureshi ◽  
Charles Mabedi ◽  
Peter Elbe ◽  
...  

2018 ◽  
Vol 55 ◽  
pp. S110
Author(s):  
N. Oussi ◽  
M. Sadeghi ◽  
J. Qureshi ◽  
C. Mabedi ◽  
P. Elbe ◽  
...  

2020 ◽  
Vol 20 (2) ◽  
pp. 977-983
Author(s):  
Aggrey Dhabangi ◽  
Ezra Musisi ◽  
Dorothy Kyeyune

Background: The majority of blood transfusion safety strategies recommended by the WHO for resource-poor countries focus mainly on reducing the risk of transfusion-transmitted infections (TTIs). Other technologies such as leucocyte reduc- tion may represent complementary strategies for improving transfusion safety. Objective: To evaluate the role of using leucocyte reduced blood in a resource-poor country. Methods: Pre-storage leucocyte reduced (LR) red blood cells (RBCs) were specially prepared for the Tissue Oxygenation by Transfusion in severe Anaemia and Lactic acidosis (TOTAL) study, at the Uganda Blood Transfusion Services from Feb- ruary 2013 through May 2015. Quality control tests were performed to evaluate the procedure, and the incremental cost of an LR–RBC unit was estimated. Results: A total of 608 RBCs units were leucocyte reduced. Quality control tests were performed on 55 random RBCs units. The median (IQR) residual leucocyte count was 4 (0•5-10) WBC/uL, equivalent to 1•8x106 WBC per unit. The estimated incremental unit cost of leucocyte reduction was $37 USD per LR RBC unit. Conclusion: Leucocyte reduction of blood in a resource-poor country is doable although relatively costly. As such, its value in resource-poor countries should be weighed against other transfusion safety propositions. Keywords: Blood transfusion safety; leucocyte reduction; resource-poor countries.


MedEdPublish ◽  
2018 ◽  
Vol 7 (3) ◽  
Author(s):  
Ninos Oussi ◽  
Mitra Sadeghi ◽  
Javeria S. Qureshi ◽  
Charles Mabedi ◽  
Peter Elbe ◽  
...  

2004 ◽  
Vol 18 (11) ◽  
pp. 658-664 ◽  
Author(s):  
Daniel W. Fitzgerald ◽  
Ascencio Maxi ◽  
Abdias Marcelin ◽  
Warren D. Johnson ◽  
Jean William Pape

Sign in / Sign up

Export Citation Format

Share Document